Cilostazol inhibits plasmacytoid dendritic cell activation and antigen presentation

BACKGROUND: Cilostazol, an anti-platelet drug for treating coronary heart disease, has been reported to modulate immune cell functions. Plasmacytoid dendritic cells (pDCs) have been found to participate in the progression of atherosclerosis mainly through interferon α (IFN-α) production. Whether cil...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Fei, Yin, Zhao, Yu, Hai-Sheng, Shi, Quan-Xing, Zhao, Bei, Zhang, Li-Guo, Wang, Shou-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554787/
https://www.ncbi.nlm.nih.gov/pubmed/26345215
http://dx.doi.org/10.11909/j.issn.1671-5411.2015.04.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4554787/
https://www.ncbi.nlm.nih.gov/pubmed/26345215
http://dx.doi.org/10.11909/j.issn.1671-5411.2015.04.011

Ejemplares similares